Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Nov 15, 2013 (Vol. 33, No. 20)


  • Good site design and organization
  • Information not very detailed (best for general audiences)

A website to be added to the list of sites employing clever acronyms, eMICE (which stands for electronic Models Information, Communication, and Education) is an online resource by the National Cancer Institute that seeks to inform the general public, scientists, and physicians about animal models used in cancer research. Information about various aspects of animal models is presented, including general information, model acquisition and generating and characterizing models. Site visitors can read about not only mice as cancer models, but also rats, hamsters, rabbits, and fish. Users can also search for animal models that are used for organ-specific cancers. (For this search, users are directed to the external cancer Models (caMOD) database.) While researchers and physicians may find the information on the site a bit elementary, eMICE does a nice job in providing general information about animals’ roles in cancer research.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »